title: Adenovirus as vector for HIV: efficacy and safety issues.
authors.affiliation: Wyeth-Ayerst Research, Biotechnology and Microbiology Division, Philadelphia, PA, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Natuk
authors.forename: M S
authors.initials: MS
authors.lastname: Wade
authors.forename: M
authors.initials: M
authors.lastname: Chengalvala
authors.forename: K K
authors.initials: KK
authors.lastname: Murthy
authors.forename: P K
authors.initials: PK
authors.lastname: Chanda
authors.forename: S C
authors.initials: SC
authors.lastname: Murthy
authors.forename: B M
authors.initials: BM
authors.lastname: Bhat
authors.forename: R
authors.initials: R
authors.lastname: Bhat
authors.forename: S K
authors.initials: SK
authors.lastname: Dheer
authors.forename: S
authors.initials: S
authors.lastname: Mizutani
mesh_terms: D016915:AIDS Vaccines / Q000009:adverse effects / Q000302:isolation & purification* / Q000592:standards; D000260:Adenoviruses, Human / Q000235:genetics / Q000276:immunology*; D000284:Administration, Oral; D000818:Animals; D005260:Female; D005822:Genetic Vectors; D015483:HIV Antibodies / Q000096:biosynthesis; D015497:HIV-1 / Q000235:genetics / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007115:Immunization Schedule; D002679:Pan troglodytes; D012449:Safety; D014614:Vaccines, Synthetic / Q000009:adverse effects / Q000302:isolation & purification* / Q000592:standards; D014779:Virus Replication
chemical_list: D016915:AIDS Vaccines; D015483:HIV Antibodies; D014614:Vaccines, Synthetic